Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement

Leukemia - Acute
Reviewers: Daniela Mihova, M.D.; Syed Zaidi, M.D. (see Reviewers page)
Revised: 27 March 2013, last major update September 2012
Copyright: (c) 2001-2013, PathologyOutlines.com, Inc.

Table of contents

Primary references   acute leukemia-general   AML general   AML classification   transient abnormal myelopoiesis

Recurrent genetic abnormalities: AML with t(6;9)   AML with t(8;21)   AML with 11q23 abnormalities   AML with inv(16) or t(16;16)   AML with Down syndrome   AML with FLT3 mutations   AML with myelodysplastic related changes   AML therapy related   APL microgranular variant   APL with t(15;17)   APL with t(V;17)   APL therapy related

AML not otherwise categorized: minimally differentiated (M0)   without maturation (M1)   with maturation (M2)   M3   myelomonocytic   monoblastic and monocytic   erythroid   megakaryoblastic   CD13/CD33 negative   basophilic   myeloid sarcoma   acute panmyelosis with myelofibrosis   with Philadelphia chromosome   with pseudo Chediak-Higashi anomaly   hypocellular

ALL: general   WHO classification   with eosinophilia

PreB ALL: general   t(9;22)   t(v;11q23)   t(1;19)   t(5;14)   t(12;21)   hyperdiploidy   hypodiploidy   mature B ALL/Burkitt

Other ALL: T ALL   ambiguous lineage   mixed phenotype

SuperPage: entire chapter


Index (table of contents in alphabetical order)

Miscellaneous: acute leukemia-general   acute panmyelosis with myelofibrosis   transient abnormal myelopoiesis

ALL: ambiguous lineage   general   mixed phenotype   WHO classification   with eosinophilia   T-ALL

B-ALL: general   mature/Burkitt   with hyperdiploidy   with hypodiploidy   with t(1;19)   with t(5;14)    with t(9;22)   with t(12;21)   with t(v;11q23)

AML: basophilic   CD13/CD33 negative   classification   erythroid   general   hypocellular   M3   megakaryoblastic   minimally differentiated (M0)   monoblastic and monocytic   myeloid sarcoma   myelomonocytic   therapy related   with 11q23 abnormalities   with Down syndrome   with FLT3 mutations   with inv(16) or t(16;16)   with maturation (M2)   with myelodysplastic related changes   with Philadelphia chromosome   with pseudo Chediak-Higashi anomaly   with t(6;9)   with t(8;21)   without maturation (M1)

APL: microgranular variant    therapy related   with t(15;17)   with t(V;17)

Primary references
top

Brunning: Tumors of the Bone Marrow (AFIP Atlas of Tumor Pathology, Series 3, Vol 9, 1994)

End of Leukemia-acute chapter